SCHEMBL19786331

SCHEMBL19786331

c1ccc(-c2nc3ccccc3nc2-n2c3ccccc3c3c4c5ccc6ccccc6c5oc4c4ccccc4c32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.36
CASP1 P29466 1/20 0.36
CYP1A1 P04798 5/20 0.34
CYP1A2 P05177 5/20 0.34
CYP1B1 Q16678 5/20 0.34
KDM4E B2RXH2 4/20 0.34
ABCG2 Q9UNQ0 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 2/20 0.34
ABCC1 P33527 2/20 0.34
PRKDC P78527 2/20 0.34
TSHR P16473 2/20 0.34
PDE5A O76074 1/20 0.34
TP53 P04637 1/20 0.34
ABCB1 P08183 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19543830 0.89 HSD17B10 (0.38) HSD17B10CASP1CYP1A1CYP1A2CYP1B1
SCHEMBL20998092 0.86 HSD17B10 (0.38) HSD17B10CASP1KDM4EALDH1A1HPGD
SCHEMBL19786325 0.85 ALDH1A1 (0.41) HSD17B10CASP1CYP1A1CYP1A2CYP1B1
SCHEMBL19543831 0.82 CYP1A1 (0.36) HSD17B10CASP1CYP1A1CYP1A2CYP1B1
SCHEMBL19507873 0.81 HSD17B10 (0.42) HSD17B10CASP1KDM4EALDH1A1HPGD
SCHEMBL19786324 0.81 CYP1A1 (0.36) HSD17B10CYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL19786685 0.80 CYP1A1 (0.33) HSD17B10CYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL20848137 0.80 HSD17B10 (0.41) HSD17B10CASP1KDM4EALDH1A1HPGD
SCHEMBL19786588 0.80 KDM4E (0.40) HSD17B10CYP1A1CYP1A2CYP1B1KDM4E
SCHEMBL24037020 0.79 HSD17B10 (0.43) HSD17B10CASP1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 HSD17B10 4178/4885CASP1 2025/4885CYP1A1 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.